Literature DB >> 28859932

The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.

Miranda Ashton1, Noelle O'Rourke2, Suzanne Currie2, Andreas Rimner3, Anthony Chalmers4.   

Abstract

Malignant pleural mesothelioma (MPM) is a devastating disease with limited treatment options and a dismal prognosis. Attempts to employ radical radiotherapy in this disease have been limited by the complex shape of the pleura and the dose restrictions necessitated by the close proximity of radiosensitive structures. Recent shifts towards a 'lung sparing' surgical approach in MPM have further heightened these challenges. The aim of this systematic review is to assess recent advances in radiotherapy planning and delivery, to ascertain how these developments have impacted on the feasibility of delivering photon-based, high-dose radiotherapy with radical intent in MPM. Three electronic databases were searched and a total of 249 articles reviewed. The challenge of generating high quality, practice-defining data for diseases such as MPM was highlighted by the identification of just two randomised studies. Much of the literature consisted of low quality, retrospective data with small cohorts and inconsistent reporting on radiotherapy techniques and dosimetry. Nevertheless, a number of prospective phase II studies were identified to suggest that radical doses of radiotherapy can be delivered safely after a lung sparing procedure in MPM, reporting encouraging survival data and acceptable levels of toxicity.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  For indexing: radiotherapy; Helical tomotherapy; Intensity modulated radiotherapy; Mesothelioma; Volumetric modulated arc radiotherapy

Mesh:

Year:  2017        PMID: 28859932      PMCID: PMC5792070          DOI: 10.1016/j.radonc.2017.08.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  71 in total

1.  Comparison of total MU and segment areas in VMAT and step-and-shoot IMRT plans.

Authors:  Motohiro Kawashima; Shuichi Ozawa; Akihiro Haga; Akira Sakumi; Chie Kurokawa; Satoru Sugimoto; Kumiko Karasawa; Keiichi Nakagawa; Keisuke Sasai
Journal:  Radiol Phys Technol       Date:  2012-07-01

2.  Deterioration in lung function following hemithorax irradiation for pleural mesothelioma.

Authors:  P Maasilta
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-03       Impact factor: 7.038

3.  Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.

Authors:  Angela Botticella; Gilles Defraene; Kristiaan Nackaerts; Christophe M Deroose; Johan Coolen; Philippe Nafteux; Stephanie Peeters; Umberto Ricardi; Dirk De Ruysscher
Journal:  Acta Oncol       Date:  2016-10-12       Impact factor: 4.089

4.  Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.

Authors:  Fauzia Shaikh; Marjorie G Zauderer; Donata von Reibnitz; Abraham J Wu; Ellen D Yorke; Amanda Foster; Weiji Shi; Zhigang Zhang; Prasad S Adusumilli; Kenneth E Rosenzweig; Lee M Krug; Valerie W Rusch; Andreas Rimner
Journal:  J Thorac Oncol       Date:  2017-03-21       Impact factor: 15.609

5.  Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?

Authors:  Andreas Rimner; Charles B Simone; Marjorie G Zauderer; Keith A Cengel; Valerie W Rusch
Journal:  Lancet Oncol       Date:  2016-02       Impact factor: 41.316

6.  Helical tomotherapy for resected malignant pleural mesothelioma: dosimetric evaluation and toxicity.

Authors:  Philippe Giraud; Alma Sylvestre; Sofia Zefkili; Albert Lisbona; Pierre Bonnette; Françoise Le Pimpec Barthes; Edouard Paris; Christian Perigaud; Alexia Savignoni; Marc-André Mahé
Journal:  Radiother Oncol       Date:  2011-08-22       Impact factor: 6.280

7.  Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; Natasha B Leighl; Andrew Hope; Thomas K Waddell; Shaf Keshavjee; B C John Cho
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-19       Impact factor: 5.209

8.  Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Claus Andrup Kristensen; Trine Juhler Nøttrup; Anne Kiil Berthelsen; Flemming Kjaer-Kristoffersen; Jesper Ravn; Jens Benn Sørensen; Svend-Aage Engelholm
Journal:  Radiother Oncol       Date:  2009-04-11       Impact factor: 6.280

9.  A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma.

Authors:  Noelle O'Rourke; Jose Curto Garcia; Jim Paul; Claire Lawless; Rhona McMenemin; Jennifer Hill
Journal:  Radiother Oncol       Date:  2007-06-22       Impact factor: 6.280

10.  Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma.

Authors:  Rea Federico; Favaretto Adolfo; Marulli Giuseppe; Spaggiari Lorenzo; DePas Tommaso Martino; Ceribelli Anna; Paccagnella Adriano; Crivellari Gino; Russo Francesca; Ceccarelli Matteo; Kazeem Gbenga; Marchi Paolo; Facciolo Francesco
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

View more
  5 in total

Review 1.  Progress in the Management of Malignant Pleural Mesothelioma in 2017.

Authors:  Amanda J McCambridge; Andrea Napolitano; Aaron S Mansfield; Dean A Fennell; Yoshitaka Sekido; Anna K Nowak; Thanyanan Reungwetwattana; Weimin Mao; Harvey I Pass; Michele Carbone; Haining Yang; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2018-03-08       Impact factor: 15.609

2.  Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.

Authors:  Christina Leitzen; Timo Wilhelm-Buchstab; Sabina Stumpf; Martina Heimann; David Koch; Christopher Schmeel; Birgit Simon; Susanne Vornholt; Stephan Garbe; Fred Röhner; Felix Schoroth; Hans Heinz Schild; Heinrich Schüller; Thomas Müdder
Journal:  Strahlenther Onkol       Date:  2019-03-26       Impact factor: 3.621

Review 3.  A Review of Pharmacologic Management in the Treatment of Mesothelioma.

Authors:  Eric P Borrelli; Conor G McGladrigan
Journal:  Curr Treat Options Oncol       Date:  2021-01-12

Review 4.  Controversies in the role of radiotherapy in pleural mesothelioma.

Authors:  Gerard G Hanna; Thomas John; David L Ball
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 5.  Cardiotoxicity of mediastinal radiotherapy.

Authors:  Ivica Ratosa; Maja Ivanetic Pantar
Journal:  Rep Pract Oncol Radiother       Date:  2019-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.